MedPath

Retinal sensitivity in branch retinal vein occlusion after anti-VEGF therapy

Not Applicable
Conditions
Branch retinal vein occlusion
Registration Number
JPRN-UMIN000017968
Lead Sponsor
Department of Ophthalmology, Fukushima Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with history of treatment for branch retinal vein occlusion, possibility of pregnancy, allergy for ranibizumab, intraocular infection or severe inflammation will be excluded.

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retinal sensitivity at 12 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath